
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.36 | 0.36 | 0.00 |
Stocks | 98.70 | 98.70 | 0.00 |
Bonds | 0.01 | 0.01 | 0.00 |
Convertible | 0.04 | 0.04 | 0.00 |
Preferred | 0.32 | 0.32 | 0.00 |
Other | 0.57 | 0.57 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.80 | 19.45 |
Price to Book | 4.37 | 4.49 |
Price to Sales | 2.11 | 2.56 |
Price to Cash Flow | 16.59 | 17.33 |
Dividend Yield | 1.27 | 1.10 |
5 Years Earnings Growth | 10.86 | 12.17 |
Number of long holdings: 108
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.98 | 813.48 | +1.48% | |
UnitedHealth | US91324P1021 | 6.62 | 488.65 | +1.48% | |
Novo Nordisk B | DK0062498333 | 3.66 | 530.2 | +0.99% | |
AstraZeneca | GB0009895292 | 3.66 | 11,994.0 | +0.94% | |
J&J | US4781601046 | 3.06 | 162.81 | -0.11% | |
Boston Scientific | US1011371077 | 2.83 | 97.16 | +1.88% | |
Amgen | US0311621009 | 2.80 | 313.71 | +0.34% | |
Abbott Labs | US0028241000 | 2.75 | 126.71 | -2.45% | |
Sanofi | FR0000120578 | 2.73 | 106.22 | 0.00% | |
AbbVie | US00287Y1091 | 2.62 | 211.77 | +0.10% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Research D | 17.49B | -1.04 | 15.15 | 13.62 | ||
Janus Balanced I | 11.93B | 2.12 | 6.71 | 8.65 | ||
Janus Enterprise I | 9.01B | 1.45 | 7.70 | 11.75 | ||
Janus Henderson Balanced Portfolio | 8.66B | 2.11 | 6.51 | 8.38 | ||
Janus Enterprise N | 6.81B | 1.47 | 7.81 | 11.85 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review